Skip main navigation (Press Enter).

Pharmaceutical Science Update

Sen. Alexander Open to New NIH Spending Authority for Opioids

NIH to Ask for Feedback on Developing Data Sharing Policy

FDA Works to Get Regenerative Medicines to Patients Faster

India's Lupin Gets FDA Warning for Two Pharma Facilities

House Tax Plan Could Drive Away Future Scientists, Groups Say

Delayed FDA Guidance Clarifies Drug Product Identifier Policy

Lawmakers Open to New Ideas to Spur Drug, Device Innovation

Korean Candymaker Warned for Drug Manufacturing Violations

First Gene Editing Clinical Trials in U.S. Could Start Next Year

FDA Seeks to Speed Approvals of Generic Drug-Device Combos

FDA on Track to OK Record Number of Devices, Generics

FDA Pushes Risk-Based Approach to Nanomaterial Drugs

Biomedical Spending Would Jump by $50 Billion under Warren Bill

Time to Get Real About Real-World Evidence, Biopharma Execs Say

FDA Updates 1990s-Era Guide on Better Drug Applications

Biosimilars Statute Trumps State Law, Appeals Court Rules

FDA Guidance: Regulations in Disguise?

FDA Closes Loophole Drugmakers Use to Avoid Pediatric Studies

New NIH Cancer Chief Mulls Changes to Improve Data Sharing

FDA to Provide More Info on Generic Application Deficiencies

FDA Proposes New Ways to Spur Precision Medicine Products

Most FDA Medicines Relied on Some NIH Funding, Analysis Finds

FDA Warns Chinese Pharmaceutical Ingredient Maker

Generic Makers Get Help Developing Abuse-Deterrent Opioids

Endo, Par Take Aim at Bulk Drug Compounding

Contact Us:

Kristen Kalmann, Content Manager
2107 Wilson Blvd. Ste. 200
Arlington, VA 22201

Advertising

View the Media Kit

AAPS Customer Service

1-703-243-2800

Copyright © 2024 AAPS Newsmagazine. All rights reserved.

Powered by Higher Logic

Global message icon